Diaceutics PLC Diaceutics Announces Key Leadership Appointment
15 Octubre 2024 - 1:00AM
RNS Non-Regulatory
RNS Number : 1382I
Diaceutics PLC
15 October 2024
RNS
Reach
Diaceutics Announces Key
Leadership Appointment
Sandra Blake appointed Chief
People Officer
Belfast and
London, 15 October 2024 - Diaceutics PLC (AIM:
DXRX), a leading technology and solutions provider to the pharma
and biotech industry, is pleased to announce the appointment of
Sandra Blake as Chief People Officer of Diaceutics PLC.
Sandra has over 25 years leadership experience
across Human Resources, Marketing & Innovation in the
Technology, Engineering, Banking, Insurance, FMCG, Retail and
Energy sectors.
Sandra has worked with companies including
NatWest Group PLC, Tesco PLC, Cadbury PLC and Kraft Foods
Inc.
Ryan Keeling,
Chief Execuitve Officer of Diaceutics
commented: "Sandra brings a wealth of operational and
management experience to the Diaceutics team and I know she will
provide a significant contribution to our performance and growth in
the future."
Sandra Blake,
Chief People Officer of Diaceutics commented:
"I am honoured and excited to
take on the role of Chief People Officer at Diaceutics. I
have followed Diaceutics' growth in recent years and am very much
looking forward to helping maximise our market opportunity by
nurturing our team's growth as we continue to drive our commercial
success."
Enquiries:
Diaceutics
PLC
|
|
Ryan Keeling, Chief Executive
Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
|
Canaccord
Genuity Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7523 8000
|
Simon Bridges, Andrew Potts, Harry
Rees
|
|
Alma Strategic
Communications
|
Tel: +44(0)20 3405 0205
|
Caroline Forde, Kinvara Verdon
|
diaceutics@almastrategic.com
|
About Diaceutics
At Diaceutics we
believe that every patient should get the opportunity to
receive the right test and the right therapy to positively impact
their disease outcome. We provide the world's leading pharma and
biotech companies with an end-to-end commercialisation solution for
precision medicines through data analytics, scientific and advisory
services enabled by our platform DXRX - The Diagnostics
Network®.
This information is provided by Reach, the non-regulatory
press release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NRAUSSBRSAURAAA
Diaceutics (LSE:DXRX)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Diaceutics (LSE:DXRX)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024